CARM
Carisma Therapeutics Inc.
Key Financials
Operating Income
$-62179000
↑ 29.9%
Revenue
$19.6M
↑ 31.5%
Net Income
$-60477000
↑ 30.4%
EPS (Diluted)
$-1.46
↑ 43.6%
Total Assets
$30.5M
↓ 66.0%
Shareholders' Equity
$26.5M
↓ 83.2%
Cash & Equivalents
$17.9M
↓ 76.9%
Total Liabilities
$58.4M
↓ 7.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 12/29/2025 | View on SEC |
| EFFECT | 12/16/2025 | View on SEC |
| EFFECT | 12/16/2025 | View on SEC |
| EFFECT | 12/16/2025 | View on SEC |
| EFFECT | 12/16/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CARM |
| Company Name | Carisma Therapeutics Inc. |
| CIK | 1485003 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 2674916422 |